PMID: 26339897Sep 5, 2015Paper

Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients

Clinical and Experimental Rheumatology
Nicola GiordanoGianluca Pecetti

Abstract

Systemic sclerosis (SSc) is a heterogeneous disorder characterised by dysfunction of the endothelium and dysregulation of fibroblasts, resulting in excessive production of collagen, and abnormalities of the immune system. Progressive fibrosis of the skin and internal organs is a pathologic hallmark of the disease, resulting in major organ damage and failure. Pulmonary hypertension (PH) is frequent in patients with SSc and, pulmonary arterial hypertension (PAH) represents one of the main causes of death. PH is not a specific disease, but a haemodynamic condition characterized by a mean pulmonary pressure ≥25mmHg. In SSc, because of the great variability in clinical manifestation, it is possible to identify pulmonary hypertension due to left heart disease, PH due to respiratory disease or pulmonary arterial hypertension. The knowledge of PH and the right diagnosis are crucial to assess the most appropriate therapeutic strategy. In this article, the new classification criteria of PH have been examined taking into account the SSc clinical evolution and focusing on the different underlying pathogenetic mechanisms.

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

International Journal of Rheumatic Diseases
Hanan Mohamed FaroukAl Hussein M El Dakrony
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
Sylwia ChwieśkoOtylia Kowal-Bielecka
© 2021 Meta ULC. All rights reserved